Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 25 entries
View as:

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Phase: N/A Priority: Normal
NCT ID: NCT00548561 Org: User:
Start: 06/30/01 End: 07/31/03 Due: 07/31/04

A Study to Assess APO866 for the Treatment of Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00432107 Org: User:
Start: 07/31/06 End: 03/31/09 Due: 03/31/10

Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01764009 Org: User:
Start: 06/30/12 End: 03/31/14 Due: 03/31/15

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT00390780 Org: User:
Start: 07/31/06 End: 01/31/08 Due: 01/31/09

A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL

Phase: N/A Priority: Normal
NCT ID: NCT00435084 Org: User:
Start: 02/28/07 End: 04/30/09 Due: 04/30/10

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00413075 Org: User:
Start: 06/30/06 End: 08/31/11 Due: 08/31/12

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Phase: N/A Priority: Normal
NCT ID: NCT00548704 Org: User:
Start: 04/30/02 End: 08/31/05 Due: 08/31/06

Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05700669 Org: User:
Start: 02/20/23 End: 10/31/23 Due: 10/31/24

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT01385748 Org: User:
Start: 04/30/10 End: 12/31/14 Due: 12/31/15

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00413322 Org: User:
Start: 09/30/05 End: 06/30/08 Due: 06/30/09

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00421889 Org: User:
Start: 08/31/05 End: 02/28/09 Due: 02/28/10

Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02548806 Org: User:
Start: 09/30/15 End: 04/30/16 Due: 04/30/17

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06257758 Org: User:
Start: 01/10/24 End: 01/01/25 Due: 01/01/26

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00131261 Org: User:
Start: 01/31/05 End: 06/30/07 Due: 06/30/08

Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01655693 Org: User:
Start: 06/30/12 End: 05/31/19 Due: 05/31/20

Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00878722 Org: User:
Start: 08/31/07 End: 04/30/12 Due: 04/30/13

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Phase: N/A Priority: Normal
NCT ID: NCT00873119 Org: User:
Start: 02/28/09 End: 12/31/12 Due: 12/31/13

A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00437736 Org: User:
Start: 02/28/07 End: 05/31/09 Due: 05/31/10

A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00878800 Org: User:
Start: 12/31/06 End: 10/31/12 Due: 10/31/13

A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00431912 Org: User:
Start: 02/28/07 End: 09/30/11 Due: 09/30/12

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00274651 Org: User:
Start: 01/31/06 End: 07/31/09 Due: 07/31/10

Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01045915 Org: User:
Start: 07/31/10 End: 01/31/13 Due: 01/31/14

Phase 3 Clinical Study for the Treatment of Cold Sore

Phase: N/A Priority: Normal
NCT ID: NCT00769314 Org: User:
Start: 05/31/07 End: 08/31/09 Due: 08/31/10

AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03579628 Org: User:
Start: 04/05/18 End: 02/20/22 Due: 02/20/23

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00431340 Org: User:
Start: 03/31/07 End: 06/30/07 Due: 06/30/08